99 related articles for article (PubMed ID: 25877939)
1. Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in metastatic brain tumor patients.
Li W; Wang Y; Zhao L; Xu L; Zhang Y; Mai L; Gao Q
Oncol Res Treat; 2015; 38(4):160-5. PubMed ID: 25877939
[TBL] [Abstract][Full Text] [Related]
2. MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer.
Wang Z; Liu Y; Zhang Y; Shang Y; Gao Q
Oncotarget; 2016 Jan; 7(4):4760-9. PubMed ID: 26716894
[TBL] [Abstract][Full Text] [Related]
3. Cytokine induced killer cell-based immunotherapies in patients with different stages of renal cell carcinoma.
Zhao X; Zhang Z; Li H; Huang J; Yang S; Xie T; Huang L; Yue D; Xu L; Wang L; Zhang W; Zhang Y
Cancer Lett; 2015 Jul; 362(2):192-8. PubMed ID: 25843292
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis on the efficacy of sunitinib/sorafenib in combination with dendritic cells-cytokine-induced killer in metastasis renal cell carcinoma after radical nephrectomy.
Mai HX; Mei GH; Zhao FL; Li BT; Tang YY; Zhang B; Xu XJ; Chen LJ
J Cancer Res Ther; 2018 Jun; 14(Supplement):S427-S432. PubMed ID: 29970701
[TBL] [Abstract][Full Text] [Related]
5. Association of myeloid-derived suppressor cells and efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma patients.
Wang Z; Zhang Y; Liu Y; Wang L; Zhao L; Yang T; He C; Song Y; Gao Q
J Immunother; 2014 Jan; 37(1):43-50. PubMed ID: 24316555
[TBL] [Abstract][Full Text] [Related]
6. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-induced killer cells in the treatment of patients with renal cell carcinoma: a pooled meta-analysis.
Wang ZX; Li JL; Cao JX; Liu YS; Li D; Zhang XY; Wang M; Wu M; Xu BL; Liu JL; Wang HB
Immunotherapy; 2014; 6(6):787-95. PubMed ID: 25186607
[TBL] [Abstract][Full Text] [Related]
8. Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells.
Han L; Shang YM; Song YP; Gao QL
J Immunol Res; 2016; 2016():5706814. PubMed ID: 27433478
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of CH-296 and interferon gamma on cytokine-induced killer cells expansion for patients with advanced-stage malignant solid tumors.
Yu J; Ren X; Li H; Cao S; Han Y; Enoki T; Kato I; Cao C; Hao X
Cancer Biother Radiopharm; 2011 Aug; 26(4):485-94. PubMed ID: 21797674
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy with cytokine-induced killer cells in metastatic renal cell carcinoma.
Su X; Zhang L; Jin L; Ye J; Guan Z; Chen R; Guo T
Cancer Biother Radiopharm; 2010 Aug; 25(4):465-70. PubMed ID: 20701541
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of autologous renal tumor cell lysate-loaded dendritic cell vaccine in combination with cytokine-induced killer cells on advanced renal cell carcinoma--a report of ten cases].
Wang H; Zhou FJ; Wang QJ; Qin ZK; Huang LX; Liu ZW; Han H; Li YQ; Chen SP; Xia JC
Ai Zheng; 2006 May; 25(5):625-30. PubMed ID: 16687087
[TBL] [Abstract][Full Text] [Related]
12. Cord blood-derived cytokine-induced killer cells biotherapy combined with second-line chemotherapy in the treatment of advanced solid malignancies.
Niu Q; Wang W; Li Y; Qin S; Wang Y; Wan G; Guan J; Zhu W
Int Immunopharmacol; 2011 Apr; 11(4):449-56. PubMed ID: 21215350
[TBL] [Abstract][Full Text] [Related]
13. Randomized study of autologous cytokine-induced killer cell immunotherapy in metastatic renal carcinoma.
Liu L; Zhang W; Qi X; Li H; Yu J; Wei S; Hao X; Ren X
Clin Cancer Res; 2012 Mar; 18(6):1751-9. PubMed ID: 22275504
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.
Wu C; Jiang J; Shi L; Xu N
Anticancer Res; 2008; 28(6B):3997-4002. PubMed ID: 19192663
[TBL] [Abstract][Full Text] [Related]
15. Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study.
Li R; Wang C; Liu L; Du C; Cao S; Yu J; Wang SE; Hao X; Ren X; Li H
Cancer Immunol Immunother; 2012 Nov; 61(11):2125-33. PubMed ID: 22581306
[TBL] [Abstract][Full Text] [Related]
16. Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients.
Yang L; Ren B; Li H; Yu J; Cao S; Hao X; Ren X
Cancer Immunol Immunother; 2013 Jan; 62(1):65-73. PubMed ID: 22744010
[TBL] [Abstract][Full Text] [Related]
17. Combination of PD-1 blockade and RetroNectin
Zhao L; Han L; Zhang Y; Li T; Yang Y; Li W; Shang Y; Lin H; Gao Q
Immunotherapy; 2018 Nov; 10(15):1315-1323. PubMed ID: 30350739
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant dendritic cells vaccine combined with cytokine-induced-killer cell therapy after renal cell carcinoma surgery.
Zheng K; Tan JM; Wu WZ; Qiu YM; Zhang H; Xu TZ; Sun XH; Zhuo WL; Wang D; Zhang JP
J BUON; 2015; 20(2):505-13. PubMed ID: 26011343
[TBL] [Abstract][Full Text] [Related]
19. Effects of cytokine-induced killer cell treatment in colorectal cancer patients: a retrospective study.
Zhang J; Zhu L; Zhang Q; He X; Yin Y; Gu Y; Guo R; Lu K; Liu L; Liu P; Shu Y
Biomed Pharmacother; 2014 Jul; 68(6):715-20. PubMed ID: 25107840
[TBL] [Abstract][Full Text] [Related]
20. Survival benefit from RectroNectin-activated cytokine-induced killer cells combined with chemotherapy in advanced EGFR wild-type lung adenocarcinoma.
Zhao L; Li W; Wang Z; Yang Y; Zhang Y; Shang Y; Ren X; Gao Q
Immunotherapy; 2018 Mar; 10(6):501-510. PubMed ID: 29562855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
